Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Clinical Trial of Structured Opioid Discontinuation Versus Continued Opioid Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioid Analgesic Therapy for Chronic Pain.

NCT02741076 is registered in ClinicalTrials.gov with Member Companies of the Opioid PMR Consortium as lead sponsor.

NCT NCT02741076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02741076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Clinical Trial of Structured Opioid Discontinuation Versus Continued Opioid Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioid Analgesic Therapy for Chronic Pain.
Lead sponsor
Member Companies of the Opioid PMR Consortium
Phase
Phase 4
Overall status
Terminated
Start date
September 14, 2016
Completion date
April 27, 2018
Enrollment
44 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

drug abuse, narcotic abuse, opiate addiction, opioid-related disorders